Cargando…

Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years

OBJECTIVES: Unsafe abortion is one of the most important causes of death and disability among mothers in countries where abortion is illegal. These conditions have changed since then. The present study has investigated the cases who were referred to the legal medicine organization to receive abortio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahdavi, Seyed Amirhosein, Jafari, Asieh, Azimi, Khadijeh, Dehghanizadeh, Nikoo, Barzegar, Abdolrazagh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254741/
https://www.ncbi.nlm.nih.gov/pubmed/32460874
http://dx.doi.org/10.1186/s13104-020-05098-y
_version_ 1783539601522032640
author Mahdavi, Seyed Amirhosein
Jafari, Asieh
Azimi, Khadijeh
Dehghanizadeh, Nikoo
Barzegar, Abdolrazagh
author_facet Mahdavi, Seyed Amirhosein
Jafari, Asieh
Azimi, Khadijeh
Dehghanizadeh, Nikoo
Barzegar, Abdolrazagh
author_sort Mahdavi, Seyed Amirhosein
collection PubMed
description OBJECTIVES: Unsafe abortion is one of the most important causes of death and disability among mothers in countries where abortion is illegal. These conditions have changed since then. The present study has investigated the cases who were referred to the legal medicine organization to receive abortion permission. This country level secondary patient data analysis, investigated all the cases who were referred to the legal medicine centers of Iran for abortion permission during 2015 to 2017. RESULTS: From 21,477 applicants, 15,617 (72.71%) received permission including 14,367 (91.99%) for fetal abnormalities and 1250 (8.01%) for maternal diseases. The most common fetal abnormalities/disorders were nervous system malformations (26.4%), chromosomal abnormalities (18.4%) and of maternal diseases were circulatory system diseases (43.9%), neoplasms (13.4%) and genitourinary system diseases (9.9%). The most common reasons for not permission were lack of supplementary documents to prove (38.8%), not competency with the criteria (33.9%), and gestational age of more than 19 weeks (25.8%).
format Online
Article
Text
id pubmed-7254741
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72547412020-06-07 Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years Mahdavi, Seyed Amirhosein Jafari, Asieh Azimi, Khadijeh Dehghanizadeh, Nikoo Barzegar, Abdolrazagh BMC Res Notes Research Note OBJECTIVES: Unsafe abortion is one of the most important causes of death and disability among mothers in countries where abortion is illegal. These conditions have changed since then. The present study has investigated the cases who were referred to the legal medicine organization to receive abortion permission. This country level secondary patient data analysis, investigated all the cases who were referred to the legal medicine centers of Iran for abortion permission during 2015 to 2017. RESULTS: From 21,477 applicants, 15,617 (72.71%) received permission including 14,367 (91.99%) for fetal abnormalities and 1250 (8.01%) for maternal diseases. The most common fetal abnormalities/disorders were nervous system malformations (26.4%), chromosomal abnormalities (18.4%) and of maternal diseases were circulatory system diseases (43.9%), neoplasms (13.4%) and genitourinary system diseases (9.9%). The most common reasons for not permission were lack of supplementary documents to prove (38.8%), not competency with the criteria (33.9%), and gestational age of more than 19 weeks (25.8%). BioMed Central 2020-05-27 /pmc/articles/PMC7254741/ /pubmed/32460874 http://dx.doi.org/10.1186/s13104-020-05098-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Note
Mahdavi, Seyed Amirhosein
Jafari, Asieh
Azimi, Khadijeh
Dehghanizadeh, Nikoo
Barzegar, Abdolrazagh
Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years
title Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years
title_full Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years
title_fullStr Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years
title_full_unstemmed Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years
title_short Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years
title_sort therapeutic abortion in iran: an epidemiologic study of legal abortion in 2 years
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254741/
https://www.ncbi.nlm.nih.gov/pubmed/32460874
http://dx.doi.org/10.1186/s13104-020-05098-y
work_keys_str_mv AT mahdaviseyedamirhosein therapeuticabortioninirananepidemiologicstudyoflegalabortionin2years
AT jafariasieh therapeuticabortioninirananepidemiologicstudyoflegalabortionin2years
AT azimikhadijeh therapeuticabortioninirananepidemiologicstudyoflegalabortionin2years
AT dehghanizadehnikoo therapeuticabortioninirananepidemiologicstudyoflegalabortionin2years
AT barzegarabdolrazagh therapeuticabortioninirananepidemiologicstudyoflegalabortionin2years